Fact CheckerSign in

NCT05575102Completed

Walking Football for People With Chronic Breathlessness

Walking Football for People With Chronic Breathlessness: a Mixed-methods Feasibility Study

Source: ClinicalTrials.gov · Last updated 10 Apr 2024

Brief summary (registry, in English)

The objective of this study is to evaluate the feasibility of a walking football intervention for people with chronic breathlessness. Chronic breathlessness refers to breathlessness that persists despite optimal treatment of the underlying pathophysiology. Roughly 9-13% of the general population will experience chronic breathlessness, with incidence rising with age to 37% for those aged over 60years. This mixed-methods study will offer patients who have enrolled on to pulmonary rehabilitation (PR) the prospect to partake in walking football once they have completed their scheduled programmes (or voluntarily dropped-out); introducing a potential opportunity for long-term exercise maintenance post PR. Participants will be recruited from North Tees \& Hartlepool Foundation Trust, and South Tees Foundation Trust. PR is recommended for all people with chronic breathlessness and has been shown to improve exercise capacity and health-related quality of life. However, PR programmes typically only last for 6-12 weeks, and have little to no impact on long-term physical activity levels. Walking Football has been identified as a potential form of exercise which people with breathlessness could maintain post-PR, thus offering a solution to PRs limited ability to promote exercise maintenance. Participants will be invited to play walking football for 6-weeks (2-hours weekly) in the Middlesbrough/Stockton area. Before and after weeks 1 and 6, breathlessness-relevant outcomes will be measured including; exercise capacity, lower-limb strength, perceived breathlessness, quality of life, balance confidence, depression, and anxiety. During a participant's third session, one-time physical intensity outcomes will be calculated during play including heart-rate and perceived intensity. Participants will also be invited to an interview to discuss how feasible they have found the football, any benefits they may have experienced, and how the football programme could be improved. The study will officially end with a co-production workshop; a focus group with stakeholders (players, physiotherapists, co-ordinators, researchers) after preliminary analysis has been conducted to discuss initial findings.

Status (registry)
Completed
Study type
Interventional
Enrollment
6 (actual)
First submitted
7 Oct 2022
Start date
22 Mar 2023
Primary completion date
29 Jun 2023
Lead sponsor
Teesside University
Diseases
COPD
NCT number
NCT05575102

What you commit to

  • Study type: Interventional
  • Participants enrolled: 6
  • From 22 Mar 2023 to the primary completion date, 29 Jun 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Unstable Angina
  • Other conditions that may affect balance (e.g. neurological)
  • Any other acute health conditions that would make activity unsafe e.g. acute infection

Other

  • Recent exacerbation of COPD (within the last six weeks)
  • Unable to provide written informed consent
  • Unable to speak English or no translation options available

Who the study is looking for

  • Confirmed diagnosis of chronic breathlessness via a chronic respiratory condition (through referral to PR)
    • Example conditions include; COPD, severe asthma, Pulmonary Fibrosis, Lung Disease (This does not include Long Covid as many patients often make a full recovery over time).
  • Be 35 years or over at the point of recruitment
  • Scheduled PR programme ends within the recruitment window
  • Be able to communicate with good verbal English or use adaptive equipment to communicate
  • Respiratory condition is stable (e.g. six weeks clear of exacerbation in COPD)

Age in the registry: 35 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tesside University
Coordinator of this site? Confirm its status
MiddlesbroughUnited KingdomUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.